The Third Refractive Surface: Improving Surgical Outcomes with Advanced Ocular Surface Diagnostics and Therapeutics

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from Allergan Inc., Shire Pharmaceuticals, TearLab, and TearScience.
    Credits: By completing this activity you will earn 2.0 AMA PRA Category 1 Credits™.
    Activity Expiration DateAugust 31, 2018

    The Third Refractive Surface: Improving Surgical Outcomes with Advanced Ocular Surface Diagnostics and Therapeutics

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    This activity is supported by educational grants from Allergan Inc., Shire Pharmaceuticals, TearLab, and TearScience.

    Credits: By completing this activity you will earn 2.0 AMA PRA Category 1 Credits™.

    Activity Expiration DateAugust 31, 2018

    Course Objectives
    Upon successful completion of this activity, participants should be able to:
    - Explain specific areas pre-operative screening and post-operative outcomes that are impacted by ocular surface disorder
    - Analyze evidence regarding advanced OSD diagnostic tools
    - Evaluate strategies for incorporating advanced diagnostics into their practice setting
    - Appropriately pair therapeutics to etiology and severity of ocular surface disease

    Product Tags

    Use spaces to separate tags. Use single quotes (') for phrases.